120 related articles for article (PubMed ID: 26902028)
41. Prognostic significance of PTEN, Ki-67 and CD44s expression patterns in gastrointestinal stromal tumors.
Liang YM; Li XH; Li WM; Lu YY
World J Gastroenterol; 2012 Apr; 18(14):1664-71. PubMed ID: 22529697
[TBL] [Abstract][Full Text] [Related]
42. Gastric Gastrointestinal Stromal Tumors (GIST): a Case Series and Current State of the Art in the Workup and Treatment of This Rare Disease.
Sharma NR; Gopakumar H; Harrison S; Ehmke N; Zelt C
J Gastrointest Cancer; 2019 Sep; 50(3):548-555. PubMed ID: 29192406
[No Abstract] [Full Text] [Related]
43. [Clinical analysis of 63 cases with gastric gastrointestinal stromal tumors].
Rong L; Wan YL; Nian WD; Liu P; Liang JY
Zhonghua Wei Chang Wai Ke Za Zhi; 2009 Jan; 12(1):24-7. PubMed ID: 19145498
[TBL] [Abstract][Full Text] [Related]
44. Analysis of the amount of tissue sample necessary for mitotic count and Ki-67 index in gastrointestinal stromal tumor sampling.
Kobara H; Mori H; Rafiq K; Fujihara S; Nishiyama N; Chiyo T; Matsunaga T; Ayaki M; Yachida T; Kato K; Kamada H; Fujita K; Morishita A; Oryu M; Tsutsui K; Iwama H; Kushida Y; Haba R; Masaki T
Oncol Rep; 2015 Jan; 33(1):215-22. PubMed ID: 25405369
[TBL] [Abstract][Full Text] [Related]
45. Risk stratification of patients diagnosed with gastrointestinal stromal tumor.
Joensuu H
Hum Pathol; 2008 Oct; 39(10):1411-9. PubMed ID: 18774375
[TBL] [Abstract][Full Text] [Related]
46. Adjuvant imatinib treatment improves recurrence-free survival in patients with high-risk gastrointestinal stromal tumours (GIST).
Nilsson B; Sjölund K; Kindblom LG; Meis-Kindblom JM; Bümming P; Nilsson O; Andersson J; Ahlman H
Br J Cancer; 2007 Jun; 96(11):1656-8. PubMed ID: 17533389
[TBL] [Abstract][Full Text] [Related]
47. Biological behavior due to cell proliferation markers of gastrointestinal stromal tumors.
Menéndez P; Padilla D; Cubo T; Villarejo P; Gambí D; Menéndez JM; Colina F; García M; Lora D; Martín J
Hepatogastroenterology; 2011; 58(105):76-80. PubMed ID: 21510290
[TBL] [Abstract][Full Text] [Related]
48. Role for p16(INK4a) in progression of gastrointestinal stromal tumors of the stomach: alteration of p16(INK4a) network members.
Mitomi H; Fukui N; Kishimoto I; Tanabe S; Kikuchi S; Saito T; Hayashi T; Yao T
Hum Pathol; 2011 Oct; 42(10):1505-13. PubMed ID: 21496871
[TBL] [Abstract][Full Text] [Related]
49. Evaluation of prognostic factors and their capacity to predict biological behavior in gastrointestinal stromal tumors.
Calabuig-Fariñas S; López-Guerrero JA; Navarro S; Machado I; Poveda A; Pellín A; Llombart-Bosch A
Int J Surg Pathol; 2011 Aug; 19(4):448-61. PubMed ID: 21427092
[TBL] [Abstract][Full Text] [Related]
50. Surgical outcomes and immunohistochemical features for gastrointestinal stromal tumors (GISTS) of the stomach: with special reference to prognostic factors.
Park SS; Ryu JS; Oh SY; Kim WB; Lee JH; Chae YS; Kim SJ; Kim CS; Mok YJ
Hepatogastroenterology; 2007; 54(77):1454-7. PubMed ID: 17708275
[TBL] [Abstract][Full Text] [Related]
51. [Clinical analysis of efficacy and prognosis of intermediate risk gastric stromal tumor patients].
Yang HX; Chen HN; Zhang B; Shen CY; Chen ZX; Chen JP
Zhonghua Yi Xue Za Zhi; 2013 Apr; 93(16):1230-3. PubMed ID: 23902613
[TBL] [Abstract][Full Text] [Related]
52. [Two cases of gastrointestinal stromal tumor (GIST) of the stomach and a consideration of its malignancy potential and treatment strategy - report of two cases].
Asakage N; Kobayashi S; Gotou T; Sasaki M; Tsukada K; Suzuki T; Yamamoto T; Sekine M; Miyazaki E; Hirai S; Yamasaki S
Gan To Kagaku Ryoho; 2007 Jun; 34(6):919-23. PubMed ID: 17565257
[TBL] [Abstract][Full Text] [Related]
53. Laparoscopic resection of clinically suspected gastric stromal tumors.
Berindoague R; Targarona EM; Feliu X; Artigas V; Balagué C; Aldeano A; Lahoud A; Navines J; Fernandez-Sallent E; Trias M
Surg Innov; 2006 Dec; 13(4):231-7. PubMed ID: 17227921
[TBL] [Abstract][Full Text] [Related]
54. Image analysis is an excellent tool for quantifying Ki-67 to predict the prognosis of gastrointestinal stromal tumor patients.
Sugita S; Hirano H; Hatanaka Y; Fujita H; Kubo T; Kikuchi N; Ito Y; Sugawara T; Segawa K; Hisai H; Yamashita K; Nobuoka T; Matsuno Y; Hasegawa T
Pathol Int; 2018 Jan; 68(1):7-11. PubMed ID: 29131458
[TBL] [Abstract][Full Text] [Related]
55. Gastrointestinal stromal tumors of the stomach and duodenum.
Cassier PA; Blay JY
Curr Opin Gastroenterol; 2011 Oct; 27(6):571-5. PubMed ID: 21934616
[TBL] [Abstract][Full Text] [Related]
56. New fronts in the adjuvant treatment of GIST.
Reichardt P; Joensuu H; Blay JY
Cancer Chemother Pharmacol; 2013 Oct; 72(4):715-23. PubMed ID: 23934322
[TBL] [Abstract][Full Text] [Related]
57. Recurrence risk after resection of gastrointestinal stromal tumors: size is not all that matters... The consequences of tumor rupture.
Han D; Deneve J; Gonzalez RJ
Am Surg; 2012 Jan; 78(1):74-9. PubMed ID: 22273319
[TBL] [Abstract][Full Text] [Related]
58. Adjuvant imatinib treatment after R0 resection for patients with high-risk gastrointestinal stromal tumors: a median follow-up of 44 months.
Jiang WZ; Guan GX; Lu HS; Yang YH; Kang DY; Huang HG
J Surg Oncol; 2011 Dec; 104(7):760-4. PubMed ID: 21713778
[TBL] [Abstract][Full Text] [Related]
59. Correlation of immunophenotype with progression-free survival in patients with gastrointestinal stromal tumors treated with imatinib mesylate.
Chirieac LR; Trent JC; Steinert DM; Choi H; Yang Y; Zhang J; Patel SR; Benjamin RS; Raymond AK
Cancer; 2006 Nov; 107(9):2237-44. PubMed ID: 16998931
[TBL] [Abstract][Full Text] [Related]
60. A Novel Pathological Prognostic Score (PPS) to Identify "Very High-Risk" Patients: a Multicenter Retrospective Analysis of 506 Patients with High Risk Gastrointestinal Stromal Tumor (GIST).
Liu X; Qiu H; Wu Z; Zhang P; Feng X; Chen T; Li Y; Tao K; Li G; Sun X; Zhou Z;
J Gastrointest Surg; 2018 Dec; 22(12):2150-2157. PubMed ID: 30030719
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
